BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

202 related articles for article (PubMed ID: 11499461)

  • 1. Effectiveness of NEO-PI-R research validity scales for discriminating analog malingering and genuine psychopathology.
    Berry DT; Bagby RM; Smerz J; Rinaldo JC; Caldwell-Andrews A; Baer RA
    J Pers Assess; 2001 Jun; 76(3):496-516. PubMed ID: 11499461
    [TBL] [Abstract][Full Text] [Related]  

  • 2. The validity and utility of the positive presentation management and negative presentation management scales for the Revised NEO Personality Inventory.
    Sellbom M; Bagby RM
    Assessment; 2008 Jun; 15(2):165-76. PubMed ID: 18463407
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Research Validity Scales for the NEO-PI-R: additional evidence for reliability and validity.
    Young MS; Schinka JA
    J Pers Assess; 2001 Jun; 76(3):412-20. PubMed ID: 11499455
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Impact of simulating borderline personality disorder on the MMPI-2: a costs-benefits model employing base rates.
    Sivec HJ; Hilsenroth MJ; Lynn SJ
    J Pers Assess; 1995 Apr; 64(2):295-311. PubMed ID: 7722855
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Effects of response sets on NEO-PI-R scores and their relations to external criteria.
    Caldwell-Andrews A; Baer RA; Berry DT
    J Pers Assess; 2000 Jun; 74(3):472-88. PubMed ID: 10900573
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Development of an Infrequency-Psychopathology scale for the MMPI-A: the Fp-A Scale.
    McGrath RE; Pogge DL; Stein LA; Graham JR; Zaccario M; Piacentini T
    J Pers Assess; 2000 Apr; 74(2):282-95. PubMed ID: 10879356
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Effects of positive impression management on the NEO Personality Inventory--Revised in a clinical population.
    Ballenger JF; Caldwell-Andrews A; Baer RA
    Psychol Assess; 2001 Jun; 13(2):254-60. PubMed ID: 11433800
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Utility of the MMPI-2-RF (Restructured Form) validity scales in detecting malingering in a criminal forensic setting: a known-groups design.
    Sellbom M; Toomey JA; Wygant DB; Kucharski LT; Duncan S
    Psychol Assess; 2010 Mar; 22(1):22-31. PubMed ID: 20230148
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The utility of the NEO-PI-R validity scales to detect response distortion: a comparison with the MMPI-2.
    Morasco BJ; Gfeller JD; Elder KA
    J Pers Assess; 2007 Jun; 88(3):276-83. PubMed ID: 17518549
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Detection of overreported psychopathology with the MMPI-2-RF [corrected] validity scales.
    Sellbom M; Bagby RM
    Psychol Assess; 2010 Dec; 22(4):757-67. PubMed ID: 21133544
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Detecting symptom exaggeration in combat veterans using the MMPI-2 symptom validity scales: a mixed group validation.
    Tolin DF; Steenkamp MM; Marx BP; Litz BT
    Psychol Assess; 2010 Dec; 22(4):729-36. PubMed ID: 21038968
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Utility of the Deceptive-Subtle items in the detection of malingering.
    Bagby RM; Nicholson R; Buis T
    J Pers Assess; 1998 Jun; 70(3):405-15. PubMed ID: 9841263
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Screening for malingering in a criminal-forensic sample with the personality assessment inventory.
    Boccaccini MT; Murrie DC; Duncan SA
    Psychol Assess; 2006 Dec; 18(4):415-23. PubMed ID: 17154762
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Experimental manipulation of NEO-PI-R items.
    Haigler ED; Widiger TA
    J Pers Assess; 2001 Oct; 77(2):339-58. PubMed ID: 11693863
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Development and validation of the Malingering Discriminant Function Index for the MMPI-2.
    Bacchiochi JR; Bagby RM
    J Pers Assess; 2006 Aug; 87(1):51-61. PubMed ID: 16856786
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Classification accuracy of MMPI-2 validity scales in the detection of pain-related malingering: a known-groups study.
    Bianchini KJ; Etherton JL; Greve KW; Heinly MT; Meyers JE
    Assessment; 2008 Dec; 15(4):435-49. PubMed ID: 18539782
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Substance or style? An investigation of the NEO-PI-R validity scales.
    Morey LC; Quigley BD; Sanislow CA; Skodol AE; McGlashan TH; Shea MT; Stout RL; Zanarini MC; Gunderson JG
    J Pers Assess; 2002 Dec; 79(3):583-99. PubMed ID: 12511022
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Detection of malingering: validation of the Structured Inventory of Malingered Symptomatology (SIMS).
    Smith GP; Burger GK
    J Am Acad Psychiatry Law; 1997; 25(2):183-9. PubMed ID: 9213290
    [TBL] [Abstract][Full Text] [Related]  

  • 19. The comparative capacity of the Minnesota Multiphasic Personality Inventory-2 (MMPI-2) and MMPI-2 Restructured Form (MMPI-2-RF) validity scales to detect suspected malingering in a disability claimant sample.
    Chmielewski M; Zhu J; Burchett D; Bury AS; Bagby RM
    Psychol Assess; 2017 Feb; 29(2):199-208. PubMed ID: 27183046
    [TBL] [Abstract][Full Text] [Related]  

  • 20. The effectiveness of MMPI-A items in discriminating between normative and clinical samples.
    Archer RP; Handel RW; Lynch KD
    J Pers Assess; 2001 Dec; 77(3):420-35. PubMed ID: 11781030
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 11.